Ever Source Wealth Advisors, LLC Tarsus Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 69 shares of TARS stock, worth $4,908. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69
Previous 14
392.86%
Holding current value
$4,908
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TARS
# of Institutions
214Shares Held
46.7MCall Options Held
7.8KPut Options Held
0-
Black Rock Inc. New York, NY3.27MShares$232 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.11MShares$221 Million1.94% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.98MShares$212 Million5.63% of portfolio
-
Jennison Associates LLC2.47MShares$176 Million0.06% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$175 Million5.96% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.9B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...